| 000 | 01784cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030322.0 | ||
| 008 | 101209s2010 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.12.02.Ph.D.2010.Mo.E | ||
| 100 | 0 | _aMohamed Saied Shaban Moafy | |
| 245 | 1 | 0 |
_aEvaluation of asymmentric dimethylarginine as a novel risk factor for cardiovascular patients / _cMohamed Saied Shaban Moafy ; Supervised Abdelgawaad Ali Fahmi , Mohammed Islam , Osama Mohamed Tayeh |
| 246 | 1 | 5 | _aتقييم دور ثنائى ميثيل الارجنين الغير متماثل كعامل خطر وذلك فى مرضى القلب والاوعية الدموية |
| 260 |
_aCairo : _bMohamed Saied Shaban Moafy , _c2010 |
||
| 300 |
_a237P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Science - Department of Biochemistry | ||
| 520 | _aThis study is an attempt to investigate the physiological and biochemical roles of plasma asymmetric dimethylarginine (ADMA) as a new risk factor in patients with cardiovascular diseases . It is concluded from the results of the present investigation that plasma asymmetric dimethylarginine levels were significantly higher in cardiovascular patients than healthy subjects | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAsymmetric dimethylarginine | |
| 653 | 4 | _aCardiovascular disease | |
| 653 | 4 | _aHypertension | |
| 700 | 0 |
_aAbdelgawaad Ali Fahmi , _eSupervisor |
|
| 700 | 0 |
_aMohammed Islam , _eSupervisor |
|
| 700 | 0 |
_aOsama Mohamed Tayeh , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c32203 _d32203 |
||